MTOR and malignant colon neoplasm: Another study implicated PDE4D in the suppression of the AKT-mechanistic target of rapamycin (mTOR)-MYC proto-oncogene, BHLH transcription factor (MYC) signaling pathway, reducing the malignant properties of colon cancer cells.67